![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ROCHE EXPECTS EU HERCEPTIN CLEARANCE FOR EARLY STAGE BREAST CANCER IN H2 2006
ROCHE EXPECTS EU HERCEPTIN CLEARANCE FOR EARLY STAGE BREAST CANCER IN H2 2006
Roche Holding AG said it expects its Herceptin drug to receive EU approval for the treatment of early stage HER-positive breast cancer within the second half of 2006. Roche is making 'considerable efforts to prepare the highest quality filing submission to the EU as early as Q1 2006' and expects an expedited review so that approval could be expected 'within the second half of 2006,' a spokeswoman for the company told AFX.
Forbes (http://www.forbes.com/markets/feeds/afx/2005/09/23/afx2240526.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct